drugset / Trial / NCT00352092
Pilot Study for HLA Identical Living Donor Renal Transplant Recipients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and effectiveness of a steroid-free and calcineurin-inhibitor free treatment regimen for patients who are receiving a kidney transplant from a living donor that is HLA-identical (has a similar immune system).
Timeline
- Start
- 2002-06
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mycophenolate Mofetil | Small molecule | — | — |
| Subject | Sirolimus | Small molecule | — | — |
| Subject | Tacrolimus | Small molecule | — | — |
Indications
No indication recorded.